{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T03:13:32Z","timestamp":1712027612372},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,12,17]],"date-time":"2010-12-17T00:00:00Z","timestamp":1292544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10822-010-9405-x","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T11:06:06Z","timestamp":1292497566000},"page":"135-144","source":"Crossref","is-referenced-by-count":6,"title":["Quantitative structure\u2013activity relationship analysis of \u03b2-amyloid aggregation inhibitors"],"prefix":"10.1007","volume":"25","author":[{"given":"Shiri","family":"Stempler","sequence":"first","affiliation":[]},{"given":"Michal","family":"Levy-Sakin","sequence":"additional","affiliation":[]},{"given":"Anat","family":"Frydman-Marom","sequence":"additional","affiliation":[]},{"given":"Yaniv","family":"Amir","sequence":"additional","affiliation":[]},{"given":"Roni","family":"Scherzer-Attali","sequence":"additional","affiliation":[]},{"given":"Ludmila","family":"Buzhansky","sequence":"additional","affiliation":[]},{"given":"Ehud","family":"Gazit","sequence":"additional","affiliation":[]},{"given":"Hanoch","family":"Senderowitz","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,12,17]]},"reference":[{"key":"9405_CR1","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/1831202a0","volume":"183","author":"AS Cohen","year":"1959","unstructured":"Cohen AS, Calkins E (1959) Electron microscopic observation on a fibrous component in amyloid of diverse origins. Nature 183:1202","journal-title":"Nature"},{"key":"9405_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033583598003400","volume":"31","author":"M Sunde","year":"1998","unstructured":"Sunde M, Blake CCF (1998) From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q Rev Biophys 31:1\u201339","journal-title":"Q Rev Biophys"},{"key":"9405_CR3","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2174\/0929867023369187","volume":"9","author":"E Gazit","year":"2002","unstructured":"Gazit E (2002) Mechanistic studies of the process of amyloid fibrils formation by the use of peptide fragments and analogues: implications of the design of fibrilization inhibitors. Curr Med Chem 9:1725\u20131735","journal-title":"Curr Med Chem"},{"key":"9405_CR4","first-page":"1121","volume":"115","author":"S Gandy","year":"2005","unstructured":"Gandy S (2005) The role of cerebral amyloid \u03b2 accumulation in common forms of Alzheimer disease. J Clin Invest 115:1121\u20131129","journal-title":"J Clin Invest"},{"key":"9405_CR5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0197-4580(89)90073-0","volume":"10","author":"D Mann","year":"1989","unstructured":"Mann D (1989) Cerebral amyloidosis aging and Alzheimer`s disease; a contribution from studies on Down`s syndrome. Neurobiol Aging 10:397\u2013399","journal-title":"Neurobiol Aging"},{"key":"9405_CR6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev.genet.32.1.461","volume":"32","author":"D Price","year":"1998","unstructured":"Price D, Tanzi R, Borchelt D, Sisodia S (1998) Alzheimer\u2019s disease: genetic studies and transgenic models. Annu Rev Genet 32:461\u2013493","journal-title":"Annu Rev Genet"},{"key":"9405_CR7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0301-0082(99)00055-6","volume":"61","author":"F Leuven Van","year":"2000","unstructured":"Van Leuven F (2000) Single and multiple transgenic mice as models for Alzheimer\u2019s disease. Prog Neurobiol 61:305\u2013312","journal-title":"Prog Neurobiol"},{"key":"9405_CR8","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","volume":"13","author":"CJ Pike","year":"1993","unstructured":"Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13:1676\u20131687","journal-title":"J Neurosci"},{"key":"9405_CR9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0306-4522(02)00241-5","volume":"114","author":"EA Grace","year":"2002","unstructured":"Grace EA, Rabiner CA, Busciglio J (2002) Characterization of neuronal dystrophy induced by fibrilar amyloid beta: implications for Alzheimer\u2019s disease. J Neurosci 114:265\u2013273","journal-title":"J Neurosci"},{"key":"9405_CR10","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1523\/JNEUROSCI.4391-04.2005","volume":"25","author":"DM Walsh","year":"2005","unstructured":"Walsh DM, Townsend M, Podlisny MB, Shankar GM, Fadeeva JV, El Agnaf O, Hartley DM, Selkoe DJ (2005) Certain inhibitors of synthetic amyloid-\u03b2 peptide (A\u03b2) fibrillogenesis block oligomerization of natural A\u03b2 and thereby rescue long-term potentiation. J Neurosci 25:2455\u20132462","journal-title":"J Neurosci"},{"key":"9405_CR11","doi-asserted-by":"crossref","first-page":"14745","DOI":"10.1073\/pnas.0905127106","volume":"106","author":"K Ono","year":"2009","unstructured":"Ono K, Condron MM, Teplow DB (2009) Structure-neurotoxicity relationships of amyloid {beta}-protein oligomers. Proc Natl Acad Sci USA 106:14745\u201314750","journal-title":"Proc Natl Acad Sci USA"},{"key":"9405_CR12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","volume":"16","author":"S Lesne","year":"2006","unstructured":"Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid beta protein assembly in the brain impairs memory. Nature 16:352\u2013357","journal-title":"Nature"},{"key":"9405_CR13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1472-8206.2008.00578.x","volume":"22","author":"RJ Marum Van","year":"2008","unstructured":"Van Marum RJ (2008) Current and future therapy in Alzheimer\u2019s disease. Fundam Clin Pharmacol 22:265\u2013274","journal-title":"Fundam Clin Pharmacol"},{"key":"9405_CR14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1357-4310(99)01508-7","volume":"5","author":"C Soto","year":"1999","unstructured":"Soto C (1999) Plaque busters: strategies to inhibit amyloid formation in Alzheimer\u2019s disease. Mol Med Today 5:343\u2013350","journal-title":"Mol Med Today"},{"key":"9405_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1741-7015-7-7","volume":"7","author":"MS Rafii","year":"2009","unstructured":"Rafii MS, Aisen PS (2009) Recent developments in Alzheimer\u2019s disease therapeutics. BMC Med 7:7","journal-title":"BMC Med"},{"key":"9405_CR16","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1002\/anie.200353565","volume":"43","author":"S Gilead","year":"2004","unstructured":"Gilead S, Gazit E (2004) Inhibition of amyloid fibril formation by peptide analogues modified with alpha-aminoisobutyric acid. Angew Chem Int Ed Engl 43:4041\u20134044","journal-title":"Angew Chem Int Ed Engl"},{"key":"9405_CR17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0925-4439(00)00034-X","volume":"1502","author":"MA Findeis","year":"2000","unstructured":"Findeis MA (2000) Approaches to discovery and characterization of inhibitors of amyloid \u03b2-peptide polymerization. Biochim Biophys Acta 1502:76\u201384","journal-title":"Biochim Biophys Acta"},{"key":"9405_CR18","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/anie.200802123","volume":"48","author":"A Frydman-Marom","year":"2009","unstructured":"Frydman-Marom A, Rechter M, Shefler I, Bram Y, Shalev DE, Gazit E (2009) Cognitive-performance recovery of Alzheimer\u2019s disease model mice by modulation of early soluble amyloidal assemblies. Angew Chem Int Ed 48:1981\u20131986","journal-title":"Angew Chem Int Ed"},{"key":"9405_CR19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jnr.20025","volume":"75","author":"K Ono","year":"2004","unstructured":"Ono K, Hasegawa K, Naiki H, Yamada M (2004) Curcumin has potent anti-amyloidogenic effects for Alzheimer\u2019s beta-amyloid fibrils in vitro. J Neurosci Res 75:742\u2013750","journal-title":"J Neurosci Res"},{"key":"9405_CR20","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bmcl.2007.11.028","volume":"18","author":"C Riviere","year":"2008","unstructured":"Riviere C, Richard T, Vitrac X, Merillon JM, Vlls J, Monti JP (2008) New polyphenols active on \u03b2-amyloid aggregation. Bioorg Med Chem Lett 18:828\u2013831","journal-title":"Bioorg Med Chem Lett"},{"key":"9405_CR21","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0798-822","volume":"4","author":"C Soto","year":"1998","unstructured":"Soto C, Sigurdsson EM, Morelli L, Kumar RA, Castano EM, Frangione B (1998) Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer\u2019s therapy. Nat Med 4:822\u2013826","journal-title":"Nat Med"},{"key":"9405_CR22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1096\/fj.01-0442hyp","volume":"16","author":"E Gazit","year":"2002","unstructured":"Gazit E (2002) A possible role for \u03c0-stacking in self-assembly of amyloid fibrils. FASEB J 16:77\u201383","journal-title":"FASEB J"},{"key":"9405_CR23","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1074\/jbc.271.15.8545","volume":"271","author":"LO Tjernberg","year":"1996","unstructured":"Tjernberg LO, N\u00e4slund J, Lindquist F, Iohansson J, Karlstr\u00f6m AR, Thyberg J, Terenius L, Nordstedt C (1996) Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem 271:8545\u20138548","journal-title":"J Biol Chem"},{"key":"9405_CR24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/0264-6021:3400283","volume":"340","author":"DR Howlett","year":"1999","unstructured":"Howlett DR, Perry AE, Godfrey F, Swatton JE, Jennings KH, Spitzfaden C, Wadsworth H, Wood SJ, Markwell RE (1999) Inhibition of fibril formation in \u03b2-amyloid peptide by a novel series of benzofurans. Biochem J 340:283\u2013289","journal-title":"Biochem J"},{"key":"9405_CR25","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1021\/bi051525c","volume":"45","author":"T Cohen","year":"2006","unstructured":"Cohen T, Frydman-Marom A, Rechter M, Gazit E (2006) Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives. Biochemistry 45:4727\u20134735","journal-title":"Biochemistry"},{"key":"9405_CR26","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2174\/0929867023369187","volume":"9","author":"E Gazit","year":"2002","unstructured":"Gazit E (2002) Mechanistic studies of the process of amyloid fibrils formation by the use of peptide fragments and analogues: implications of the design of fibrilization inhibitors. Curr Med Chem 9:1725\u20131735","journal-title":"Curr Med Chem"},{"key":"9405_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1747-0285.2005.00318.x","volume":"67","author":"Y Porat","year":"2006","unstructured":"Porat Y, Abramowitz A, Gazit E (2006) Inhibiton of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibiton mechanism. Chem Biol Drug Des 67:7\u201337","journal-title":"Chem Biol Drug Des"},{"key":"9405_CR28","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1021\/bi800043d","volume":"47","author":"M Levy","year":"2008","unstructured":"Levy M, Porat Y, Bacharach E, Shalev DE, Gazit E (2008) Phenolsulfonphthalein, but not phenolphthalein, inhibits amyloid fibril formation: implications for the modulation of amyloid self-assembly. Biochemistry 47:5896\u20135904","journal-title":"Biochemistry"},{"key":"9405_CR29","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.bmcl.2008.12.049","volume":"19","author":"JL Simons","year":"2009","unstructured":"Simons JL, Caprathea BW, Callahana M, Grahama JM, Kimurab T, Laia Y, LeVine H, Lipinskia IW, Sakkaba AT, Tasakib Y, Walkera LC, Yasunagab T, Yea Y, Zhuanga N, Augelli-Szafran CE (2009) The synthesis and structure\u2013activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors. Bioorg Med Chem Lett 19:654\u2013657","journal-title":"Bioorg Med Chem Lett"},{"key":"9405_CR30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1747-0285.2007.00557.x","volume":"70","author":"AA Reinke","year":"2007","unstructured":"Reinke AA, Gestwicki JE (2007) Structure\u2013activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem Biol Drug Des 70:206\u2013215","journal-title":"Chem Biol Drug Des"},{"key":"9405_CR31","unstructured":"Discovery Studio, Accelrys, Inc. http:\/\/www.accelrys.com\/dstudio\/"},{"key":"9405_CR32","unstructured":"http:\/\/www.cs.waikato.ac.nz\/ml\/weka"},{"key":"9405_CR33","volume-title":"An introduction to probability theory and its applications","author":"W Feller","year":"1950","unstructured":"Feller W (1950) An introduction to probability theory and its applications, vol 1. Wiley, New York"},{"key":"9405_CR34","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1021\/jm0303195","volume":"47","author":"X Xia","year":"2004","unstructured":"Xia X, Maliski EG, Gallant P, Rogers D (2004) Classification of kinase inhibitors using a Bayesian Model. J Med Chem 47:4463\u20134470","journal-title":"J Med Chem"},{"key":"9405_CR35","volume-title":"C4.5: programs for machine learning","author":"RJ Quinlan","year":"1993","unstructured":"Quinlan RJ (1993) C4.5: programs for machine learning. Morgan Kaufmann Publishers, San Mateo"},{"key":"9405_CR36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","volume":"27","author":"T Fawcett","year":"2006","unstructured":"Fawcett T (2006) An introduction to ROC analysis. Pattern Recognit Lett 27:861\u2013874","journal-title":"Pattern Recognit Lett"},{"key":"9405_CR37","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/ci700157b","volume":"47","author":"C Rucker","year":"2007","unstructured":"Rucker C, Rucker G, Meringer MY (2007) Randomization and its variants in QSPR\/QSAR. J Chem Inf Model 47:2345\u20132357","journal-title":"J Chem Inf Model"},{"key":"9405_CR38","doi-asserted-by":"crossref","unstructured":"Irwin JJ, Shoichet BK (2005) ZINC\u2014A free database of commercially available compounds for virtual screening ( http:\/\/zinc.docking.org ). J Chem Inf Model 45:177\u2013182","DOI":"10.1021\/ci049714+"},{"key":"9405_CR39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1107\/S0108768102003890","volume":"58","author":"FH Allen","year":"2002","unstructured":"Allen FH (2002) The cambridge structural database: a quarter of a million crystal structures and rising. Acta Cryst B 58:380\u2013388","journal-title":"Acta Cryst B"},{"key":"9405_CR40","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neulet.2008.08.052","volume":"444","author":"T Akaishi","year":"2008","unstructured":"Akaishi T, Morimotoa T, Shibaoa M, Watanabea S, Sakai-Katob K, Utsunomiya-Tateb N, Abe K (2008) Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid \u03b2 protein. Neurosci Lett 444:280\u2013285","journal-title":"Neurosci Lett"},{"key":"9405_CR41","doi-asserted-by":"crossref","first-page":"42881","DOI":"10.1074\/jbc.M206593200","volume":"277","author":"HA Lashuel","year":"2002","unstructured":"Lashuel HA, Hartley DM, Balakhaneh D, Aggarwal A, Teichberg S, Callaway DJ (2002) New class of inhibitors of amyloid-beta fibril formation. Implications for the mechanism of pathogenesis in Alzheimer\u2019s disease. J Biol Chem 277:42881\u201344290","journal-title":"J Biol Chem"},{"key":"9405_CR42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0968-0004(99)01445-0","volume":"24","author":"CM Dobson","year":"1999","unstructured":"Dobson CM (1999) Protein misfolding, evolution and disease. Trends Biochem Sci 24:329\u2013332","journal-title":"Trends Biochem Sci"},{"key":"9405_CR43","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.bmc.2006.09.069","volume":"15","author":"C Riviere","year":"2007","unstructured":"Riviere C, Richard T, Quentin L, Krisa S, Merillon JM, Mont JP (2007) Inhibitory activity of stilbenes on Alzheimer\u2019s b-amyloid fibrils in vitro. Bioorg Med Chem 15:1160\u20131167","journal-title":"Bioorg Med Chem"},{"key":"9405_CR44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/ci00001a012","volume":"31","author":"LH Hall","year":"1991","unstructured":"Hall LH, Mohney B, Kier LB (1991) The electrotopological state: structure information at the atomic level for molecular graphs. J Chem Inf Comput Sci 31:76\u201382","journal-title":"J Chem Inf Comput Sci"},{"key":"9405_CR45","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1021\/ci990140w","volume":"40","author":"LH Hall","year":"2000","unstructured":"Hall LH, Kier LB (2000) The E-state as the basis for molecular structure space definition and structure similarity. J Chem Inf Comput Sci 40:784\u2013791","journal-title":"J Chem Inf Comput Sci"},{"key":"9405_CR46","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/pro.87","volume":"18","author":"M Convertino","year":"2009","unstructured":"Convertino M, Pellarin R, Catto M, Carotti A, Caflish A (2009) 9, 10-anthraquinone hinders \u03b2-aggregation: how does a small molecule interfere with A\u03b2 -peptide amyloid fibrillation? Protein Sci 18:792\u2013800","journal-title":"Protein Sci"},{"key":"9405_CR47","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1111\/j.1742-4658.2007.06158.x","volume":"274","author":"D Morshedi","year":"2007","unstructured":"Morshedi D, Rezaei-Ghaleh N, Ebrahim-Habibi A, Ahmadian S, Nemat-Gorgani M (2007) Inhibition of amyloid fibrillation of lysozyme by indole derivatives\u2014possible mechanism of action. FEBS J 274:6415\u20136425","journal-title":"FEBS J"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-010-9405-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-010-9405-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-010-9405-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T02:36:32Z","timestamp":1712025392000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-010-9405-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,17]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["9405"],"URL":"https:\/\/doi.org\/10.1007\/s10822-010-9405-x","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,17]]}}}